Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by alltalkon Apr 13, 2021 4:20pm
222 Views
Post# 32987122

It was a blast while it lasted

It was a blast while it lastedWell guys, I'm I've been a long-hauler in THRM, and regretted not having sold my sizeable portion back in early January for an easy triple-up. But today is the day that I dumped my entire position. I'm still up a little, but not as much as I had hoped in the end. I seriously thought I had struck gold!

Of immense concern to me is the wording of today's new release, that it "detected the wuhan orginal," with no mention whatsoever of the variants which are running rampant of late and must have surely been part of their testing process.

The fact that the news release was worded so specifically is a huge red flag to me. My read on this release is that the variants reduce the test's sensitivity and specificity by 15-20%. If that's the case, then the current test will need to be adjusted.

Will it then require a revision and resubmission? How long with that process take? One month? Three months?

After having been burned badly by SONA about six months ago and not trusting the abundance of red flags on display at the time, this time I am.

I hope that I'm wrong and wish you guys all the best. Many of us come here for ideas and insight towards our main end goal --- investing in winners and making money.

Peace out brothers!
<< Previous
Bullboard Posts
Next >>